Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?

  title={Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?},
  author={Jeffrey M. Robbins and Gerald J Strauss and David Clark Aron and Jodi H. D. Long and Jennifer L Kuba and Yelena L. Kaplan},
  journal={Journal of the American Podiatric Medical Association},
  volume={98 6},
Five-year mortality rates after new-onset diabetic ulceration have been reported between 43% and 55% and up to 74% for patients with lower-extremity amputation. These rates are higher than those for several types of cancer including prostate, breast, colon, and Hodgkin's disease. These alarmingly high 5-year mortality rates should be addressed more aggressively by patients and providers alike. Cardiovascular diseases represent the major causal factor, and early preventive interventions to… 

Figures from this paper

Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes.

Diabetic Foot Ulcers: Evaluation and Management

Assessment and control of infection are critical, including determining the severity of the infection, which may drive therapeutic approaches, and adjuvant therapies are used to hasten the healing process.

Current Concepts Review: Diabetic Foot Ulcers

  • D. Wukich
  • Medicine
    Foot & ankle international
  • 2010
The pathophysiology, work-up, and management of diabetic foot ulcers are discussed and evidence-based recommendations for available treatment options will also be presented.

The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk.

Mortality Risk of Charcot Arthropathy Compared With That of Diabetic Foot Ulcer and Diabetes Alone

Charcot arthropathy was significantly associated with higher mortality risk than diabetes alone and with lower risk thanFoot ulcer tended to have a higher prevalence of peripheral vascular disease and macrovascular diseases than patients with CharcotArthropathy, which may explain the difference in mortality risks between the two groups.

Preventing amputations in patients with diabetes and renal disease

There is evidence to suggest that the organisation of care could have an impact on the onset of foot disease in patients with diabetes, and these patients therefore should have regular foot surveillance, education, and support from appropriate specialists to manage their foot care.

Intensive versus conventional glycaemic control for treating diabetic foot ulcers.

A review of published, unpublished, ongoing, ongoing and terminated clinical trials to assess the effects of intensive glycaemic control compared to conventional control on the outcome of foot ulcers in people with type 1 and type 2 diabetes failed to find any completed randomised clinical trials with results.

Challenges Of Caring For Diabetic Foot Ulcers In Resource-Poor Settings

Patient education about foot care as well as frequent and detailed foot assessment by the health care providers may reduce the prevalence of foot ulceration and lower extremity amputation.

Diabetic foot disease on the renal unit

The risk of foot ulcers or major limb amputation appears to accelerate soon after the start of renal replacement therapy, and professionals involved in the care of patients with diabetes and renal disease should be aware of the extent to which the patients’ feet are at risk.



Amputation and Mortality in New-Onset Diabetic Foot Ulcers Stratified by Etiology

All types of diabetic foot ulcers are associated with high morbidity and mortality, and the increased mortality appears to be independent of factors increasing ulcer risk—that is, neuropathy and PVD—in patients with established foot Ulcers.

Guest Editorial: are diabetes‐related wounds and amputations worse than cancer?

It is fairly evident based on data that all types of diabetic foot ulcers are associated with high morbidity and mortality, and peripheral vascular disease may be implicated as a significant factor associated with shorter life span.

Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

The results appear to support the value of foot-ulcer prevention programs for patients with diabetes and the attributable cost of care compared with that in patients without foot ulcers.

New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up.

It is believed that the use of therapeutic shoes and intense educational training, including the education of the family, have contributed to the low incidence of new ulceration and major amputation in the study population.

Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study.

LEA is a potent predictor of all-cause and CVD mortality in diabetic American Indians and the combination of female sex and LEA is associated with greater risk ofCVD mortality than either factor alone.

Mortality and Hospitalization in Patients After Amputation

After LEA, patients with diabetes have an increased risk of death compared with nondiabetic patients, and efforts should be made to minimize these risks with aggressive treatment of cardiovascular risk factors and management of cardiac failure.

Midfoot Amputations Expand Limb Salvage Rates for Diabetic Foot Infections

Overall limb salvage for TMA/midfoot procedures was estimated to be 73%, 68%, and 62% at 1, 3, and 5 years, respectively, with only 50% of dialysis patients avoiding major amputation.

Long‐term prognosis for diabetic patients with foot ulcers

The recurrence of foot ulcer as well as the cumulative amputation and mortality rates in diabetic patients with previous foot ulcers are evaluated.

The epidemiology of lower-extremity disease in veterans with diabetes.

Veterans with diabetes comprise a significant proportion of hospitalizations for lower-extremity ulceration, peripheral vascular bypass, and amputation, and age-specific rates of diabetic amputation in veterans are lower than U.S. rates.

Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study.

All-cause mortality is high after an amputation in both diabetic and nondiabetic patients, and prevention of these complications is warranted to prevent amputations and the subsequent high mortality.